ABOUT
 BREAST CANCER TRIALS

Founded in 1978, Breast Cancer Trials is the largest independent oncology clinical trials research organisation in Australia and New Zealand.

Pictured: Ms Kathleene Dower is a senior radiation therapist at the North Coast Cancer Institute at Lismore Base Hospital in NSW and is a 2025 Breast Cancer Trials clinical fellow.

With over 1,014 researchers across 118 institutions, we lead the way in international, multi-centre clinical trials that test the benefits of new breast cancer treatments and prevention strategies.

Our mission is to provide critical answers that inform better clinical practices and treatment guidelines, and ultimately saves lives.

Every clinical trial we conduct contributes to our understanding of breast cancer, driving forward new treatments that make a difference to those impacted by this disease.

Our success is powered by the collaboration of a vast network of researchers, institutions, clinical trial participants and supporters. This means we are able to pool our resources and expertise to answer some of the most pressing questions in breast cancer research and areas of unmet need. This collective effort ensures that we accelerate our progress and deliver life-saving treatments sooner, all while maintaining the highest standards of scientific rigour and integrity.

Our work directly contributes to saving lives and improving the quality of life for breast cancer patients. By testing new treatments, refining existing ones, and focusing on prevention, we are determined to end the suffering caused by breast cancer.

Our research doesn’t just impact the present – it builds the future, creating a world where breast cancer no longer cuts lives short. This vision is what drives every trial, every discovery, and every person involved in our organisation.

As we look ahead, our dedication to this vision grows stronger. Every step we take in our clinical trials brings us closer to a world where breast cancer is no longer a life-threatening diagnosis.

The path forward is clear: through continued innovation, collaboration, and a steadfast commitment to scientific excellence, we will ensure that no more lives are cut short by breast cancer. Together, we will make this vision a reality – for today’s patients, and for generations to come.

Rebecca Pickering is a participant in the OLIO clinical trial.